Abstract
Impact of COVID-19 on outpatient therapy with iloprost for systemic sclerosis digital ulcers.
Highlights
Introduction and objectivesThe outbreak of COVID-19 epidemic imposed temporary changes in the management of patients with chronic diseases
digital ulcers (DU) were evaluated with DUCAS (DU Clinical Assessment Score)
The 2 groups had similar rate of new DU during the emergency period, but DUCAS slightly increased during therapy discontinuation, decreasing after resuming it
Summary
The outbreak of COVID-19 epidemic imposed temporary changes in the management of patients with chronic diseases. We analyzed the impact of COVID-19 epidemic in patients with Systemic Sclerosis (SSc) receiving intravenous iloprost infusions for digital ulcers (DU) treatment
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
